Top compounds associated with response to DHX16


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA neratinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.097 0.002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.095 0.002
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.1 0.003
mRNA thapsigargin gCSI pan-cancer AAC 0.17 0.003
Download CSV